Bio-Thera Gets Chinese Nod To Proceed On Ustekinumab

China’s NMPA Gives Go-Ahead For Phase I Trial On Stelara Biosimilar

 
• By Penelope MacRae
  
China
China has given Bio-Thera approval to proceed with a Phase I ustekinumab trial • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products